ATDC KEAPs NRF2 active

ATDC promotes pancreatic cancer progression and chemoresistance by disrupting KEAP1-mediated ubiquitylation of NRF2.

Source: Signal Transduction Knowledge Environment - February 9, 2021 Category: Science Authors: VanHook, A. M. Tags: STKE Editors ' Choice Source Type: news